BioXcel Therapeutics Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting.

BioXcel Therapeutics Inc. published this content on April 22, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 07, 2026 at 16:36 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]